Drreddys Laboratories | RDY - Interest Expense On Debt


Drreddys Laboratories reported INR944M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
ANI Pharmaceuticals USD 4.73M 711K Sep/2025
Aurora Cannabis CAD 2.22M 442K Sep/2025
Bayer EUR 762M 267M Sep/2025
Canopy Growth CAD 8.8M 938K Sep/2025
Cipla INR 140.3M 8.5M Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Drreddys Laboratories INR 944M 127M Dec/2025
GlaxoSmithKline GBP 167M 17M Sep/2025
Hikma Pharmaceutical USD 20M 2M Jun/2025
Lonza CHF 84M 14M Jun/2025
Novartis USD 281M 8M Sep/2025
Pacira USD 4.28M 456K Sep/2025
Prestige Brands USD 10.04M 167K Sep/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sun Pharmaceuticals INR 998.6M 250.6M Sep/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Teva Pharmaceutical Industries USD 220M 17M Dec/2025